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ABSTRACT Many toxins and antimicrobial peptides permeabilize membrane vesicles by forming multimeric pores. Deter-
mination of the size of such pores is an important first step for understanding their structure and the mechanism of their
self-assembly. We report a simple method for sizing pores in vesicles based on the differential release of co-encapsulated
fluorescently labeled dextran markers of two different sizes. The method was tested using the bee venom peptide melittin,
which was found to form pores of 25-30 A diameter in palmitoyloleoylphosphatidylcholine (POPC) vesicles at a lipid-to-
peptide ratio of 50. This result is consistent with observations on melittin pore formation in erythrocytes (Katsu, T., C.
Ninomiya, M. Kuroko, H. Kobayashi, T. Hirota, and Y. Fujita. 1988. Action mechanism of amphipathic peptides gramicidin S
and melittin on erythrocyte membrane. Biochim. Biophys. Acta. 939:57-63).
INTRODUCTION
Induced permeabilization of cell membranes is one of the
most common killing mechanisms of peptides that have
cytotoxic or host-defense functions. For several such pep-
tides, formation of multimeric pores has been suggested to
be responsible for membrane permeabilization (Rapaport et
al., 1996; Rex, 1996; Schwarz and Arbuzova, 1995; Ma-
tsuzaki et al., 1994; Wimley et al., 1994; Schwarz et al.,
1992; Parente et al., 1990). The first step toward under-
standing the structure and function of such pores is the
determination of their size as gauged by the dimensions of
the molecules able to pass through them. This is usually
done by measuring the leakage of markers of different sizes
through the pore in consecutive experiments (Rex, 1996;
Wimley et al., 1994; Ostolaza et al., 1993; Sabirov et al.,
1990; Parente et al., 1990; Katsu et al., 1988; Tosteson et
al., 1985). In addition to the time required to carry out
consecutive experiments, unavoidable variations in experi-
mental conditions, such as the concentrations of lipid and
peptide, can make the approach cumbersome to implement
and interpret. The basic approach would be greatly simpli-
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fied, and strengthened, if the sizing of the pores could be
accomplished in a single experiment.
We describe here a simple method for sizing pores in
lipid vesicles based on the differential release of co-encap-
sulated markers of different sizes. Vesicles are preloaded
with fluorescently labeled dextrans FD-4 (4.4 kDa mol wt)
and FD-70 (50.7 kDa mol wt) and then incubated with the
leakage-inducing agent. The relative release of the two
markers is determined quantitatively by means of a flow-
through cuvette placed in a fluorescent spectrometer that
monitors the elution profile from a gel filtration column.
The method was tested using the bee venom peptide melit-
tin, which is known to cause hemolysis (Katsu et al., 1988;
Tosteson et al., 1985; DeGrado et al., 1982) and to induce
leakage of fluorescent dyes from lipid vesicles (Rex, 1996;
Benachir and Lafleur, 1995; Ladokhin et al., 1995; Schwarz
et al., 1992). In our study, melittin was found to release 88%
of FD-4 but only 22% of FD-70 from large unilamellar
POPC vesicles at a lipid-to-peptide ratio of 50. Based on
these data, we estimate that the average pore diameter is
25-30 A, consistent with observations on melittin hemoly-
sis of erythrocytes (Katsu et al., 1988).
MATERIALS AND METHODS
Materials
POPC was obtained from Avanti Polar-Lipids (Birmingham, AL). Melittin
(sequencing grade), Triton X-100, FD-4 dextran, and FD-70 dextran were
obtained from Sigma (St. Louis, MO) and Sephacryl S-400 HR from
Pharmacia Biotech (Uppsala, Sweden). The buffer solution (pH = 7.0)
used for most experiments contained 10 mM HEPES, 50 mM KCI, 1 mM
EDTA, and 3 mM NaN3. Buffer for melittin samples contained 4 mM
EDTA. The buffer was carefully degassed before each run to avoid for-
mation of air bubbles on the column.
Choice of column media for gel filtration
The implementation of the method depends crucially on the quality of the
separation of dextran-loaded vesicles from the two sizes of released dex-
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trans. The gel filtration system used must satisfy three criteria. First, a good
general resolution of the components must be achieved. Second, because
the three components in the injected mixture (vesicles, larger marker, and
smaller marker) cover a wide range of sizes, the range must be matched by
the resolving ability of the column. Third, both vesicles and dextrans have
a distribution of sizes that causes broadening of the elution profiles. This
has implications which are discussed in Results and Discussion. We found
that Sephacryl S-400 HR satisfied these criteria and permitted separation of
LUV from FD-70 and FD-4.
Preparation of dextran-loaded vesicles and
leakage experiments
LUV of -0.1 Am diameter were formed by extrusion under N2 pressure
through Nucleopore polycarbonate membranes using the method of Mayer
et al. (1986). To prepare LUV with entrapped solutes, the lipid was
suspended in buffer containing 2 mg/ml FD-4 and 4 mg/ml FD-70, and was
then frozen and thawed 20 times before extrusion, and several additional
times during the extrusion process. Untrapped dextran was removed by gel
filtration using Sephacryl S-400 HR packed into a 38 X 1-cm column run
at 12 ml/h controlled by a P-1 peristaltic pump (Pharmacia Biotech,
Uppsala, Sweden). At the concentration of dextran used for encapsulation,
no self-quenching was observed. Fluorescein dextran-containing LUV
were treated either with Triton, to determine the ratio of entrapped dex-
trans, or with melittin, to examine differential dextran release. The treated
LUV were applied at 4.6 ml/h to a column connected to a 176.752-QS
flow-through fluorescence cuvette (Hellma, Germany) placed in an SLM-
8100 fluorimeter (SLM/Aminco, Urbana, IL). Excitation and emission
wavelengths were 490 nm (4-nm slits) and 530 nm (16-nm slits), respec-
tively. During the initial separation, the slits were 1 nm and 2 nm,
respectively. A polarizer oriented horizontally was introduced into the
emission path to minimize scattering artifacts. All experiments were car-
ried out at room temperature (23°C).
Data analysis
Elution profiles were determined by measuring relative fluorescence in-
tensity I (sampled at 10-s intervals) as a function of time t. We found that
the elution profiles for a single dextran species could be represented
accurately as log-normal distributions, as has been observed in diverse
spectroscopic analyses of complex spectra (Donoso et al., 1993; Johnson
and Metzler, 1970). We therefore estimated the fractions of FD-4 and
FD-70 released by determining the areas of elution profiles obtained from
best-fit log-normal distributions:
1989). The resulting computed log-normal distribution was then subtracted
from the complete profile, leaving a two-peak distribution corresponding to
the two classes of dextrans released from the vesicles. This residual
distribution was then fitted to a sum of two log-normal distributions
corresponding to released FD-70 and FD-4. During the latter fit, a single
parameter (of the remaining eight) corresponding to the asymmetry of the
least-resolved FD-70 peak was fixed at a PFD-70 = 1.3 value determined
independently from the elution of profile of the free dextran (data not
shown). The areas under the peaks were calculated numerically using
software package Origin 3.5 (MicroCal, Inc., Northampton, MA). The
relative fractions of individual markers were calculated from the ratios of
the areas of the individual peaks for samples with partially and completely
released contents. Complete release was achieved by treating vesicles with
0.5% Triton X-100. The uncertainties in fractions were estimated to be
0.05.
RESULTS AND DISCUSSION
The first step in the development of the method was the
characterization of the encapsulation process. Fig. 1 shows
the elution profile associated with the separation of LUV-
encapsulated FD-4 and FD-70 from unencapsulated dex-
trans. A 0.3-ml sample containing 70 mM POPC vesicles
was applied to a 38 X 1 cm Sephacryl S-400 HR column
connected to a flow-through cuvette placed in the SLM-
8100 fluorescence spectrometer. Conditions of excitation
and emission were selected to follow the fluorescence of
labeled dextrans and to minimize the contribution from
scattering (see Methods). Dextran-loaded LUV appear close
to the void volume at 15 ml and are well separated from the
free FD-70 and FD-4 peaks, which appear at 23 and 28 ml,
respectively.
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where i = LUV, FD-70, or FD-4; and Ii, ti, Fi, and pi are four parameters
of the distribution, corresponding to maximal intensity, position of maxi-
mum, width, and asymmetry, respectively.
The typical release experiment results in an overlapping three-peak
elution profile so that 12 parameters are required to describe it. This large
number of parameters was found to cause instabilities if fitted simulta-
neously in a single pass. The following procedure was therefore used. The
data in the early phase of release (1 x 104 to 1.5 X 104 s) corresponding
to the LUV-encapsulated dextrans were fitted with a single log-normal
distribution using the Marquardt-Levenberg fitting algorithm (Press et al.,
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FIGURE 1 Elution profile demonstrating the separation of LUV with
co-encapsulated fluorescently labeled dextrans FD-4 and FD-70 from
unencapsulated markers. A 0.3-ml sample containing 70 mM POPC ves-
icles formed in the presence of FD-4 and FD-70 was applied on 38 x 1 cm
Sephacryl S-400 HR gel filtration column connected to a flow-through
cuvette placed in a fluorescence spectrometer. The flow rate was 12 ml/h.
The shaded area corresponds to the fraction of LUV used in further studies.
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The fraction of LUV eluted between 14.0 and 16.5 ml
was used for all further studies (shaded area in Fig. 1). This
fraction, when run on the same column, elutes as a single
peak as shown by the dashed curve in Fig. 2. To verify that
both markers were indeed encapsulated, the vesicles were
disrupted with Triton X-100 before application on the col-
umn. Fig. 2 shows that the single LUV peak is replaced by
two well-resolved peaks corresponding to the now-free
FD-70 and FD-4 (solid curve). The change in the relative
areas of the FD-4 and FD-70 peaks seen in Fig. 2, compared
with Fig. 1, indicates less efficient encapsulation of the
larger dextran. To check for the possibility of interactions of
the dextrans with vesicle surfaces, we added dextrans ex-
ternally to "empty" LUV, and then passed the mixture
through the column. No fluorescence was observed at elu-
tion volumes corresponding to the LUV (data not shown).
We therefore concluded that the fluorescence corresponding
to the LUV peak arose solely from entrapped dextrans.
The Triton disruption experiment serves two purposes: it
allows one to estimate the ratio of the entrapped dyes and to
control the quality of the separation of unentrapped dextrans
from dextran-loaded LUV. This is necessary because com-
mercially available dextrans have a distribution of sizes so
that a dextran of specified molecular weight contains sig-
nificant percentages of dextrans that are both larger and
smaller than the specified characteristic size. If the initial
separation of the large unentrapped dextrans from the ves-
icles is inadequate, there will be a population of large
dextrans that can co-migrate with the loaded vesicles. When
the sample is subsequently re-run through the column after
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FIGURE 2 Elution profile for the LUV with co-encapsulated FD-4 and
FD-70 in the absence and presence of Triton X-100. Dashed curve on left
is the profile for untreated (intact) vesicles. The twin-peaks profile, solid
curve, results when vesicles are disrupted with 0.5% reduced Triton X-100,
and demonstrates that both FD-4 and FD-70 are co-encapsulated in vesi-
cles. For both elution profiles, 0.2-ml samples containing 2 mM POPC
were run through the same column as in Fig. 1, but at 4.6 ml/h.
incubation with a permeabilizing peptide, this fraction can
cause the amount of release to be underestimated. The
addition of Triton allows this fraction of dextrans to be
easily detected as an extra peak early in the elution. Exper-
iments of this kind showed that other gels, such as Sephadex
G-100, for example, do not give a complete separation of
LUV and dextrans larger than FD-4 (data not shown). The
use of Sephacryl S-400 HR, however, resulted in complete
separation, as evidenced by the data of Fig. 2.
A peptide that forms pores, defined as passageways of
any kind that have limited apertures, will lead to leakage of
vesicle contents in a manner that depends on the size of the
solute. If, however, the peptide acts in a detergent-like
manner and "dissolves" (micellizes) the membrane, there
should be no preference in the release of markers of differ-
ent sizes. If pores or other leakage pathways are very small,
then no release of dextrans will be detected. The application
of the method was tested using the well-studied membrane-
active peptide, melittin.
Melittin was found to cause the release of both markers,
but to significantly different extents as shown in Fig. 3 by
the fact that the FD-4 peak is much larger than the FD-70
peak in the elution profile (solid line). This indicates the
formation of a pore rather than disruption through a deter-
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FIGURE 3 Release of fluorescently labeled dextrans from POPC vesi-
cles induced by melittin. A 0.3-ml sample containing 28 ,uM melittin and
1.4 mM POPC LUV preloaded with FD-4 and FD-70 was incubated for 3 h
and then applied to the gel filtration column (same conditions as in Fig. 2).
The solid curve is the observed time trace of the elution profile. The dashed
lines are the log-normal approximations of individual components corre-
sponding to (from left to right) LUV encapsulated dextrans, released
FD-70, and released FD-4. The dotted curve is the sum of the log-normal
distributions of the individual components. It demonstrates that the relative
amounts of FD-4 and FD-70 released can be accurately determined by
means of the log-normal fitting procedure. The release of FD-4 by melittin
is much more effective as compared with the release of FD-70, indicating
the formation of pores -25-30 A in diameter under these conditions (see
text).
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gent-like action or some other "collective membrane per-
turbation" (Benachir and Lafleur, 1995). To quantitate the
preference of the release, the elution profile was decom-
posed into three components: unreleased dextrans, released
FD-70, and released FD-4, each of which can be approxi-
mated as log-normal distributions as described in Methods
(dashed lines, Fig. 3). The sum of these computed log-
normal distributions, shown as the dotted line in Fig. 3,
coincides well with the actual data (solid line). The fractions
of FD-4 and FD-70 released from the vesicles by melittin
are estimated to be 88% and 22%, respectively. This result
was reproduced within the uncertainty of the method (see
Methods) in a second run under identical conditions (not
shown).
The effective hydrodynamic radii for FD-4 and FD-70 are
estimated to be 18 and 50 A, respectively, from the data of
Bohrer et al. (1979). However, as the study of Bohrer et al.
indicates, the dextrans are best modeled as prolate ellip-
soids. By extrapolation from Bohrer et al.'s data, we esti-
mate that the full length of the short axis is -20 A for both
dextrans, while the long axes are -40 and 440 A for FD-4
and FD-70, respectively. A pore aperture of 25-30 A should
therefore allow a relatively free passage of FD-4 while
reducing significantly the leakage of FD-70, which might
pass through the pore by reptation. A pore of this aperture
should allow complete leakage of smaller molecules such as
calcein, carboxifluorescein, and ANTS/DPX. Indeed, all of
those markers have been reported to be completely released
from vesicles at lipid-to-protein ratios below the value of 50
used here (Rex, 1996; Benachir and Lafleur, 1995;
Ladokhin et al., 1995; Schwarz et al., 1992).
Consistent with our results, studies on osmotic protection
of erythrocytes led to an estimated pore size of -20-30 A
at high melittin concentrations (Katsu et al., 1988). These
protection experiments also showed that the size of pores
formed by melittin or another peptide, gramicidin S, in-
creased with peptide concentration. For gramicidin S, the
degree of hemolysis dropped abruptly with an increase of
solute size (Katsu et al., 1988), whereas for melittin, a rather
broad transition occurs (Sabirov et al., 1990). This behavior
can be rationalized by assuming that melittin forms pores
that have a rather wide distribution of sizes. This suggests
that our estimate for the pore diameter should be attributed
to a mean pore size characteristic of the distribution. A
significant population of larger pores could result in en-
hanced release of FD-70 while having little effect on the
release of FD-4. In such a case, the ratio of the fractional
release of two dextrans is expected to decrease as the width
of distribution of pore sizes increases.
Melittin's secondary structure in membranes is well es-
tablished to be highly a-helical, but its degree of aggrega-
tion and its membrane orientation are subjects of continuing
debate [see Dempsey (1990) for review]. A reasonable view
at the present time is that multiple aggregated forms of
melittin can exist in membranes that are affected by tem-
perature, lipid composition, and lipid-to-peptide ratio. One
such form may consist of aggregates containing transbilayer
helices (Vogel and Jahnig, 1986). In that case, our estimate
for the pore size of 25-30 A in inner diameter suggests that
10-15 monomers would be required. This is quite reason-
able, because under conditions used in our measurement
each vesicle, on average, should contain 2000 melittin mol-
ecules, assuming a mole-fraction partition coefficient of
4 105 (W. C. Wimley, A. S. Ladokhin, and S. H. White,
unpublished observations). Thus, the number of monomers
is more than sufficient to form at least one pore per vesicle,
assuming a modest equilibrium constant between monomers
and multimers.
Leakage irduction by melittin has been studied exten-
sively and the formation of small pores (10 A in diameter)
has been suggested to be responsible for leakage of the
small dye carboxyfluorescein (Rex, 1996; Schwarz et al.,
1992). These studies were, however, confined to relatively
low peptide concentrations (Ri = 200-2000). On the other
hand, at extremely high concentrations (Ri < 20) a complete
loss of vesicular structure has been demonstrated (Dufourcq
et al., 1986; Monette and Lafleur, 1996). One can rational-
ize two possibilities for the intermediate case of moderate
concentrations: 1) the number of pores increases, but their
size remains fixed; or 2) the average multiplicity of aggre-
gates increases, leading to larger pores, which allow the
leakage of larger molecules. Our result on melittin pore
formation in POPC vesicles obtained for Ri = 50 suggest
the second possibility, consistent with studies on erythro-
cytes (Katsu et al., 1988).
We have demonstrated that measurement of the leakage
of co-encapsulated markers of different sizes provides a fast
and convenient way of sizing membrane pores. The method
eliminates the unavoidable variations in experimental con-
ditions that occur when pores are sized through measure-
ments of leakage in consecutive experiments. The complete
characterization of pore formation by uncharacterized pep-
tides will require studies with several sets of co-encapsu-
lated markers to explore a wide range of concentrations and
sizes. For an extremely well-studied peptide, a single ex-
periment can yield new information as we have demon-
strated in the case of melittin.
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